| 2025 | 2024 | 2023 | 2022 | 2021 | 2019 | 2018 | 2017 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 80,6 M € | +22.2% | 66,0 M € | +15.9% | 56,9 M € | +3.1% | 55,2 M € | +3.3% | 53,4 M € | +33.7% | 40,0 M € | +20.1% | 33,3 M € | +41.6% | 23,5 M € | +14.5% | 20,5 M € | +6.9% | 19,2 M € | +23.1% | 15,6 M € | +15.7% | 13,5 M € | +36.6% | 9,9 M € | +234.9% | 2,9 M € | |
| EBITDA | 4,2 M € | +31.0% | 3,2 M € | +4.2% | 3,1 M € | +13.0% | 2,7 M € | +19.6% | 2,3 M € | +455.7% | -636,4 k € | -303.1% | 313,3 k € | -73.2% | 1,2 M € | -2.3% | 1,2 M € | +7.0% | 1,1 M € | +100.9% | 557,3 k € | -31.0% | 807,2 k € | +311.5% | -381,7 k € | +22.7% | -494,1 k € | |
| Operating profit | 3,9 M € | +36.3% | 2,9 M € | +5.5% | 2,7 M € | +20.7% | 2,3 M € | +11.4% | 2,0 M € | +277.1% | -1,2 M € | -3300.9% | 36,0 k € | -96.2% | 960,2 k € | -7.7% | 1,0 M € | +9.2% | 952,9 k € | +106.0% | 462,6 k € | -36.3% | 726,3 k € | +249.2% | -486,8 k € | +4.8% | -511,1 k € | |
| Profit/loss | 2,9 M € | +36.5% | 2,1 M € | +0.6% | 2,1 M € | +20.5% | 1,7 M € | +11.3% | 1,6 M € | +229.4% | -1,2 M € | -1902.8% | -60,4 k € | -110.4% | 581,5 k € | -40.4% | 975,1 k € | +285.6% | 252,9 k € | -2.7% | 260,0 k € | -55.4% | 582,8 k € | +217.8% | -494,6 k € | +4.7% | -518,8 k € | |
| Equity | 2,1 M € | -2.8% | 2,1 M € | +7.8% | 2,0 M € | +8.2% | 1,8 M € | +1929.3% | 90,3 k € | -74.8% | 358,4 k € | -77.1% | 1,6 M € | -3.7% | 1,6 M € | +4.4% | 1,6 M € | -1.4% | 1,6 M € | +19.0% | 1,3 M € | +24.3% | 1,1 M € | +119.8% | 486,5 k € | +110.5% | 231,2 k € | |
| Total assets | 32,4 M € | +79.7% | 18,0 M € | -2.9% | 18,6 M € | +22.6% | 15,2 M € | -14.8% | 17,8 M € | -11.0% | 20,0 M € | +3.0% | 19,4 M € | +135.1% | 8,3 M € | -12.7% | 9,5 M € | +35.1% | 7,0 M € | +12.3% | 6,2 M € | +30.0% | 4,8 M € | +17.6% | 4,1 M € | +48.4% | 2,7 M € | |
| Cash | 2,9 k € | -99.4% | 479,9 k € | +4467.7% | 10,5 k € | +0.7% | 10,4 k € | -98.5% | 701,4 k € | +135.2% | 298,2 k € | +623.9% | 41,2 k € | -95.5% | 916,9 k € | -65.4% | 2,7 M € | +180.2% | 946,9 k € | -13.5% | 1,1 M € | +64726.8% | 1,7 k € | -99.8% | 707,7 k € | — | ||
| Debts | 30,3 M € | +90.2% | 15,9 M € | -4.2% | 16,6 M € | +24.8% | 13,3 M € | -24.7% | 17,7 M € | -8.6% | 19,3 M € | +10.6% | 17,5 M € | +174.4% | 6,4 M € | -18.4% | 7,8 M € | +81.9% | 4,3 M € | -7.4% | 4,6 M € | +37.1% | 3,4 M € | +2.3% | 3,3 M € | +31.2% | 2,5 M € | |
| Staff | 47,1 | 38,4 | 34,2 | 36,5 | 46,6 | 55,3 | 49,2 | 45,4 | 38,7 | 35,1 | 34,6 | 33,3 | 30,6 | 16,8 | ||||||||||||||
Public limited company · Zaventem · incorporated on 15/06/2010 · 47,1 ETP
Public limited company profitable and well capitalised. Cash position declining (-99.4%).
Solid counterparty for a standard engagement.
CHIESI is a Public limited company incorporated in 2010. Its main activity is: Commerce de gros de produits pharmaceutiques et médicaux. Its registered office is in Zaventem. It employs on average 47,1 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette